A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
AvenCell Therapeutics, Inc.
Audubon Bioscience
Global BioClinical
Celgene
Acrotech Biopharma Inc.
Aprea Therapeutics